Clinical Trial

BeFlared Versus VBX for FEVAR

Study acronym: BRAVE FEVAR
Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled unblinded trial aimes to compare BeFlared FEVAR Stent Graft System (BeFlared) with GORE® VIABAHN® VBX Balloon Expandable Endoprothesis (VBX) in patients undergoing endovascular aneurysm repair with fenestrated device (FEVAR). Primary objectives: * compare cumulative device time between patients undergoing FEVAR with BeFlared and VBX brindging device; * compare target vessel (TV) instability at early, short-term and midterm follow-up in patients undergoing FEVAR with BeFlared and VBX brindging device. Secondary objectives: \- compare intraoperative TV technical success in patients undergoing FEVAR with BeFlared and VBX bridging device.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-16.
Status change: Not Yet Recruiting → Recruiting 2026-02-24
Trial Details
NCT Number NCT07424885
Lead Sponsor Medical University of Vienna
Conditions Fenestrated Endovascular Aortic Repair
Enrollment 126 participants
Start Date 2026-02-19
Primary Completion 2033-02 (estimated)
Study Completion 2033-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-27